Mia's Feed
Medical News & Research

Experts Advocate for Patient-Centered AI Regulations in Healthcare to Prevent Discrimination

Experts Advocate for Patient-Centered AI Regulations in Healthcare to Prevent Discrimination

Share this article

Experts emphasize the importance of patient-centered regulation for AI in healthcare to prevent discrimination and protect individual rights amid rapid technological advances.

2 min read

A recent commentary published in the Journal of the Royal Society of Medicine emphasizes the urgent need for a patient-centered approach to regulate artificial intelligence (AI) in healthcare. While AI and machine learning tools have the potential to improve clinical precision, current risk-based regulatory frameworks—like the European Union's AI Act of 2025—are falling short in safeguarding patients from over- and undertreatment as well as discrimination.

The authors highlight concerns over AI systems' inherent biases, lack of transparency, and potential inaccuracies which are not sufficiently addressed by existing regulations. The EU’s AI Act classifies medical AI as "high risk" and enforces strict controls on providers, but it overlooks critical issues such as individual patient preferences, the systemic and long-term impacts of AI deployment, and the disempowerment of patients in decision-making processes.

Lead author Professor Thomas Ploug from Aalborg University stresses that regulation must go beyond systemic safety and protect individual rights by incorporating patient participation. He advocates for establishing explicit patient rights in AI-driven care, including the right to explanations, to consent or withdraw consent, to seek second opinions, and to refuse diagnoses or screenings based on publicly available data.

The article warns that without proactive engagement from clinicians, regulators, and patient advocacy groups, these rights could be neglected amid rapid technological advancements. AI's influence in health care must be balanced with the preservation of patient autonomy and trust. The authors call for regulatory reforms that recognize these individual rights and ensure patients remain empowered in an AI-integrated healthcare system.

This discussion underscores the importance of evolving regulations to prioritize patient rights alongside technological innovation. For more details, see the full study: DOI: 10.1177/01410768251344707.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Rising STD Rates in Texas Counties Highlight Public Health Concerns

Recent reports show rising rates of sexually transmitted infections in Texas counties, with Dallas and Harris leading the country's top hotspots. Learn about the causes, statistics, and resources to combat this public health issue.

Medical Debt Often Persists After Cancer Diagnosis, Study Finds

New research shows that small amounts of medical debt in collections can persist for years after a cancer diagnosis, highlighting the need for financial support for patients.

Emerging Molecule Offers Hope for Treating MASH, Endometriosis, and Other Chronic Conditions

A new small molecule, Bobcat339, shows promise in selectively targeting harmful macrophages associated with chronic diseases like MASH, endometriosis, and cancer, offering hope for innovative treatments.

Study Identifies Age 70 as the Threshold for Chemotherapy Effectiveness in Colorectal Cancer Patients

A comprehensive study reveals that patients aged 70 or younger with stage III colorectal cancer benefit from oxaliplatin-based chemotherapy, while older patients do not, guiding personalized treatment strategies.